Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Cancers
|
November 27, 2021
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
Constantinos Zamboglou, Simon K B Spohn, Sonja Adebahr, et al.
Cancers
|
November 27, 2021
Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
Eleni Gkika, Sonja Adebahr, Anton Brenner, et al.
Radiation Oncology (London, England)
|
August 7, 2024
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on <sup>18</sup>F-PSMA-1007 PET
Julius C Holzschuh, Michael Mix, Martin T Freitag, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 3, 2026
How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations
T Willigenburg, C Draulans, F J Pos, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
Simone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
January 25, 2024
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)
S A Koerber, S Höcht, D Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 28, 2024
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)
C Zamboglou, D M Aebersold, C Albrecht, et al.
Frontiers in Oncology
|
August 1, 2022
Intraindividual Comparison Between [<sup>18</sup>F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients
Ioana M Marinescu, Simon K B Spohn, Selina Kiefer, et al.
European Urology
|
January 21, 2025
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
Vedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 25, 2025
Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)
S K B Spohn, D M Aebersold, C Albrecht, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Cancers
|
November 27, 2021
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
Constantinos Zamboglou, Simon K B Spohn, Sonja Adebahr, et al.
Cancers
|
November 27, 2021
Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
Eleni Gkika, Sonja Adebahr, Anton Brenner, et al.
Radiation Oncology (London, England)
|
August 7, 2024
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on <sup>18</sup>F-PSMA-1007 PET
Julius C Holzschuh, Michael Mix, Martin T Freitag, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 3, 2026
How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations
T Willigenburg, C Draulans, F J Pos, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
Simone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
January 25, 2024
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)
S A Koerber, S Höcht, D Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 28, 2024
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)
C Zamboglou, D M Aebersold, C Albrecht, et al.
Frontiers in Oncology
|
August 1, 2022
Intraindividual Comparison Between [<sup>18</sup>F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients
Ioana M Marinescu, Simon K B Spohn, Selina Kiefer, et al.
European Urology
|
January 21, 2025
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
Vedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 25, 2025
Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)
S K B Spohn, D M Aebersold, C Albrecht, et al.
Page
of 8